Friends of MannKInd

[Phaeton]

Had Breakfast this AM with a friend who is going to go on Afrezza



Had Breakfast this morning this AM with a Friend who is a 65 Year old diabetic. He has been on once a day Lantus injections. His Endo has recommended that he start taking Meal time insulin injections. This friend who has invested in MannKind asked his Endo about Afrezza. vs mealtime injections. The Endo Smiled at him and asked him what he knew about the product and he told the Endo. Seems that the Endo knew about Afrezza but was not going to put patients on it unless they asked for it as its too new. Once the friend indicated that he wanted it the Doctor stated he had no issue with it and would prescribe it to him. That in fact it would be his first patient on it and that he was excited to do it. The Dr. Did not have the ability to do the Testing and my friend will go back to see him next week to get the prescription after he takes the pulmonary test.

As I have stated before that Afrezza will be a viral product that Doctor's will prescribe only when the demand is there and not before that time. So don't look at weekly script counts but look at the viral nature of patients who learn about Afrezza from friends and sources like blogs. Long term we will have a great increase in PPS as diabetics learn about Afrezza.